$ANIP Recent News Stocks to Watch Friday: Morg
Post# of 144482
Posted On: 01/04/2015 10:42:13 AM
$ANIP Recent News
Stocks to Watch Friday: Morgan Stanley 3:40 p.m. Oct. 4, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:24 p.m. Oct. 4, 2012 - MarketWatch
BioSante to merge with ANI in all-stock deal 9:56 a.m. Oct. 4, 2012 - MarketWatch.com
AMAG, Takeda Mutually End Agreement for Feraheme - Analyst Blog 6:30 p.m. Dec. 30, 2014 - Zacks.com
BioMarin's Vimizim OK'd in Japan for Morquio A Syndrome - Analyst Blog 5:10 p.m. Dec. 30, 2014 - Zacks.com
Xenon Pharmaceuticals (XENE) Jumps: Stock Surges 16.8% - Tale of the Tape 9:11 a.m. Dec. 30, 2014 - Zacks.com
Commit To Buy ANI Pharmaceuticals At $50, Earn 21.5% Annualized Using Options 11:35 a.m. Dec. 29, 2014 - TheStreet.com
Actelion Submits New Drug Application for Uptravi in the U.S. - Analyst Blog 5:35 p.m. Dec. 23, 2014 - Zacks.com
Stryker & Osiris Team Up to Market Viable Bone Matrix - Analyst Blog 3:50 p.m. Dec. 23, 2014 - Zacks.com
Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog 2:30 p.m. Dec. 23, 2014 - Zacks.com
Genomic Health (GHDX) Shines on Prospective Cancer Tests - Analyst Blog 5:50 p.m. Dec. 22, 2014 - Zacks.com
Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog 1:40 p.m. Dec. 19, 2014 - Zacks.com
Bruker Unveils bioAFM System for High Resolution Imaging - Analyst Blog 2:40 p.m. Dec. 18, 2014 - Zacks.com
Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog 6:00 p.m. Dec. 16, 2014 - Zacks.com
Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog 5:46 p.m. Dec. 16, 2014 - Zacks.com
Genomic Health's Breast Cancer Test Yields Positive Results - Analyst Blog 2:30 p.m. Dec. 16, 2014 - Zacks.com
OvaScience Slumps: OVAS Tanks 12.3% in Session - Tale of the Tape 9:06 a.m. Dec. 16, 2014 - Zacks.com
BioDelivery Sciences (BDSI) in Focus: Stock Tanks 11% - Tale of the Tape 9:02 a.m. Dec. 16, 2014 - Zacks.com
bluebird bio (BLUE) Crumbles: Stock Falls by 5.6% - Tale of the Tape 8:38 a.m. Dec. 16, 2014 - Zacks.com
One Stock Chart Trick You Should All Know - Investment Ideas 1:00 a.m. Dec. 16, 2014 - Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog 6:15 p.m. Dec. 15, 2014 - Zacks.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape 9:46 a.m. Dec. 15, 2014 - Zacks.com
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference 8:30 a.m. Dec. 11, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces Closing of 3.00% Convertible Senior Notes and Full Exercise of Over-Allotment Option 12:33 p.m. Dec. 10, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering 8:23 a.m. Dec. 5, 2014 - PR Newswire - PRF
ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes 9:00 a.m. Dec. 4, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights 8:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results 7:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire 3:30 p.m. Aug. 1, 2014 - PR Newswire - PRF
Global Women%s Health Market 2014-2018 5:20 p.m. July 28, 2014 - PR Newswire - PRF
Global Transdermal Drug Delivery Market 2014-2018 4:22 p.m. July 28, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 7:30 a.m. July 28, 2014 - PR Newswire - PRF
RestorGenex Announces Management Changes 6:00 a.m. July 9, 2014 - BusinessWire - BZX
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 5:00 a.m. July 4, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Acquires Lithobid® Extended Release Tablets from Noven Therapeutics 9:50 a.m. July 1, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Signs Exclusive License and Supply Agreement with Dexcel Pharma Technologies Ltd. 7:30 a.m. June 18, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Expands Product Development Collaboration with Sofgen 8:00 a.m. May 1, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for First Quarter 2014 Financial Results 7:30 a.m. April 28, 2014 - PR Newswire - PRF
Upcoming Conference Calls, Commencement of Shipments, Stock Price Movements, Awareness Campaigns, and Acquisitions - Analyst Notes on Incyte, Impax, ANI, Ironwood and Aastrom 7:00 a.m. April 24, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Presents at 26th Annual ROTH Conference 4:00 p.m. March 10, 2014 - PR Newswire - PRF
Stocks to Watch Friday: Morgan Stanley 3:40 p.m. Oct. 4, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:24 p.m. Oct. 4, 2012 - MarketWatch
BioSante to merge with ANI in all-stock deal 9:56 a.m. Oct. 4, 2012 - MarketWatch.com
AMAG, Takeda Mutually End Agreement for Feraheme - Analyst Blog 6:30 p.m. Dec. 30, 2014 - Zacks.com
BioMarin's Vimizim OK'd in Japan for Morquio A Syndrome - Analyst Blog 5:10 p.m. Dec. 30, 2014 - Zacks.com
Xenon Pharmaceuticals (XENE) Jumps: Stock Surges 16.8% - Tale of the Tape 9:11 a.m. Dec. 30, 2014 - Zacks.com
Commit To Buy ANI Pharmaceuticals At $50, Earn 21.5% Annualized Using Options 11:35 a.m. Dec. 29, 2014 - TheStreet.com
Actelion Submits New Drug Application for Uptravi in the U.S. - Analyst Blog 5:35 p.m. Dec. 23, 2014 - Zacks.com
Stryker & Osiris Team Up to Market Viable Bone Matrix - Analyst Blog 3:50 p.m. Dec. 23, 2014 - Zacks.com
Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog 2:30 p.m. Dec. 23, 2014 - Zacks.com
Genomic Health (GHDX) Shines on Prospective Cancer Tests - Analyst Blog 5:50 p.m. Dec. 22, 2014 - Zacks.com
Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog 1:40 p.m. Dec. 19, 2014 - Zacks.com
Bruker Unveils bioAFM System for High Resolution Imaging - Analyst Blog 2:40 p.m. Dec. 18, 2014 - Zacks.com
Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog 6:00 p.m. Dec. 16, 2014 - Zacks.com
Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog 5:46 p.m. Dec. 16, 2014 - Zacks.com
Genomic Health's Breast Cancer Test Yields Positive Results - Analyst Blog 2:30 p.m. Dec. 16, 2014 - Zacks.com
OvaScience Slumps: OVAS Tanks 12.3% in Session - Tale of the Tape 9:06 a.m. Dec. 16, 2014 - Zacks.com
BioDelivery Sciences (BDSI) in Focus: Stock Tanks 11% - Tale of the Tape 9:02 a.m. Dec. 16, 2014 - Zacks.com
bluebird bio (BLUE) Crumbles: Stock Falls by 5.6% - Tale of the Tape 8:38 a.m. Dec. 16, 2014 - Zacks.com
One Stock Chart Trick You Should All Know - Investment Ideas 1:00 a.m. Dec. 16, 2014 - Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog 6:15 p.m. Dec. 15, 2014 - Zacks.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape 9:46 a.m. Dec. 15, 2014 - Zacks.com
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference 8:30 a.m. Dec. 11, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces Closing of 3.00% Convertible Senior Notes and Full Exercise of Over-Allotment Option 12:33 p.m. Dec. 10, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering 8:23 a.m. Dec. 5, 2014 - PR Newswire - PRF
ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes 9:00 a.m. Dec. 4, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights 8:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results 7:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire 3:30 p.m. Aug. 1, 2014 - PR Newswire - PRF
Global Women%s Health Market 2014-2018 5:20 p.m. July 28, 2014 - PR Newswire - PRF
Global Transdermal Drug Delivery Market 2014-2018 4:22 p.m. July 28, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 7:30 a.m. July 28, 2014 - PR Newswire - PRF
RestorGenex Announces Management Changes 6:00 a.m. July 9, 2014 - BusinessWire - BZX
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 5:00 a.m. July 4, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Acquires Lithobid® Extended Release Tablets from Noven Therapeutics 9:50 a.m. July 1, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Signs Exclusive License and Supply Agreement with Dexcel Pharma Technologies Ltd. 7:30 a.m. June 18, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Expands Product Development Collaboration with Sofgen 8:00 a.m. May 1, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Schedules Conference Call for First Quarter 2014 Financial Results 7:30 a.m. April 28, 2014 - PR Newswire - PRF
Upcoming Conference Calls, Commencement of Shipments, Stock Price Movements, Awareness Campaigns, and Acquisitions - Analyst Notes on Incyte, Impax, ANI, Ironwood and Aastrom 7:00 a.m. April 24, 2014 - PR Newswire - PRF
ANI Pharmaceuticals Presents at 26th Annual ROTH Conference 4:00 p.m. March 10, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼